Lupin Limited (Lupin), global pharmaceutical company, announced the appointment of Mark D. McDade as an Independent Director effective January 28, 2021. McDade is the co-Founder and Partner at Qiming Venture Partners, USA where he led several high-value investments in biotherapeutics, including cell and gene therapy and digital health. With a career spanning over 37 years,…